Enumeral Biomedical Corp. engages in the discovery of native human monoclonal antibodies for use in the diagnosis and treatment of infectious, autoimmune and inflammatory diseases. Our proprietary microengraving technology creates spatially-registered, high-density bio-chip microarrays of the secreted products of single human cells derived from patient samples to provide rapid and simultaneous analysis of antibody affinity and specificity as well as cytokine profiles and T-cell functionality. The technology provides similarly efficient measures of single-cell secreted products to gauge and improve product quality from production cell lines.

Back to home Page top